Ror1 is upregulated in lung cancer and has been associated with resistance to Tyrosine Kinase Inhibitor (TKIs) therapy in epidermal growth factor receptor (EGFR) positive NSCLC [95,96]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.